Chemopreventive effects of NSAIDs as inhibitors of cyclooxygenase-2 and inducers of apoptosis in experimental lung carcinogenesis

Setia, Shruti; Vaish, Vivek; Sanyal, Sankar
July 2012
Molecular & Cellular Biochemistry;Jul2012, Vol. 366 Issue 1/2, p89
Academic Journal
Roles of cyclooxygenase (COX) enzyme and intrinsic pathway of apoptosis have been explored for the chemopreventive effects of non-steroidal anti-inflammatory drugs (NSAIDs) on 9,10-dimethyl benz(a)anthracene (DMBA)-induced lung cancer in rat model. 16 weeks after the administration of DMBA, morphological analysis revealed the occurrences of tumours and lesions, which were regressed considerably with the co-administration of indomethacin and etoricoxib, the two NSAIDs under investigation. DMBA group was marked by hyperplasia and dysplasia as observed by histological examination, and these features were corrected to a large extent by the two NSAIDs. Elevated levels of COX-2 were seen in the DMBA group, the enzyme responsible for prostaglandin synthesis during inflammation and cancer, whilst the expression of the constitutive isoform, COX-1, was equally expressed in all the groups. Apoptosis was quantified by studying the activities of apaf-1, caspase-9, and 3 by immunofluorescence and western blots. Their activities were found to diminish in the DMBA-treated animals as compared to the other groups. Fluorescent co-staining of the isolated broncho-alveolar lavage cells showed reduced number of apoptotic cells in the DMBA group, indicating decrease in apoptosis after carcinogen administration. The present results thus suggest that the mechanism of cancer chemoprevention of NSAIDs may include the suppression of COX-2 and the induction of apoptosis.


Related Articles

  • Pfizer ceases Bextra sales.  // Chemical Market Reporter;4/11/2005, Vol. 267 Issue 15, p4 

    Reports on Pfizer Inc.'s decision to pull its Cox-2 inhibitor Bextra off the market at the request of the U.S. Food and Drug Administration, which has criticized the overall risk-to-benefit profile of the drug. Agency's additional requirement that the company add a black-box warning to its...

  • The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Asher, Viren; Warren, Averil; Shaw, Robert; Sowter, Heidi; Bali, Anish; Khan, Raheela // Cancer Cell International;2011, Vol. 11 Issue 1, p6 

    Background: The voltage gated potassium (K+) channels Eag and HERG have been implicated in the pathogenesis of various cancers, through association with cell cycle changes and programmed cell death. The role of these channels in the onset and progression of ovarian cancer is unknown. An...

  • Hsp70 Architecture: The Formation of Novel Polymeric Structures of Hsp70.1 and Hsc70 after Proteotoxic Stress. Steel, Rohan; Cross, Ryan S.; Ellis, Sarah L.; Anderson, Robin L. // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    Heat induces Hsp70.1 (HSPA1) and Hsc70 (HSPA8) to form complex detergent insoluble cytoplasmic and nuclear structures that are distinct from the cytoskeleton and internal cell membranes. These novel structures have not been observed by earlier immunofluorescence studies as they are obscured by...

  • Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes. Brandt, Bettina; Büchse, Tom; Abou-Eladab, Ehab; Tiedge, Markus; Krause, Eberhard; Jeschke, Udo; Walzel, Hermann // Histochemistry & Cell Biology;May2008, Vol. 129 Issue 5, p599 

    Galectin-1 (gal-1), a member of the family of β-galactoside binding proteins, participates in several biological processes such as immunomodulation, cell adhesion, regulation of cell growth and apoptosis. The aim of this study was to investigate whether gal-1 interferes with the Fas...

  • Cyclooxygeanse-2 promotes metastasis in osteosarcoma. Liyan Qu; Bing Liu // Cancer Cell International;2015, Vol. 15 Issue 1, p1 

    Cyclooxygenase-2 (COX-2), an inducible form of the enzyme that catalyzes the first step in the synthesis of prostanoids, is associated with carcinogenesis, which is suspected to promote angiogenesis and tissue invasion of tumors and resistance to apoptosis. COX-2 is also involved in metastasis...

  • Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants. Lecleire-Collet, A.; Tessier, L. H.; Massin, P.; Forster, V.; Brasseur, G.; Sahel, J. A.; Picaud, S. // British Journal of Ophthalmology;Dec2005, Vol. 89 Issue 12, p1631 

    Background/aims: Neuronal degeneration has been reported to occur in diabetic retinopathy before the onset of detectable microvascular abnormalities. To investigate whether advanced glycation end products (AGE) could be directly responsible for retinal neurodegeneration, retinal explants were...

  • Silibinin induces apoptosis via calpain-dependent AIF nuclear translocation in U87MG human glioma cell death. Jeong, Ji C.; Shin, Won Y.; Kim, Thae H.; Kwon, Chae H.; Kim, Jae H.; Kim, Yong K.; Kim, Ki H. // Journal of Experimental & Clinical Cancer Research (17569966);2011, Vol. 30 Issue 1, p44 

    Background: Silibinin, a natural polyphenolic flavonoid, has been reported to induce cell death in various cancer cell types. However, the molecular mechanism is not clearly defined. Our previous study showed that silibinin induces glioma cell death and its effect was effectively prevented by...

  • Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines. Labovsky, Vivian; Fern�ndez Vallone, Valeria B.; Martinez, Leandro M.; Otaegui, Julian; Chasseing, Norma A. // Cancer Cell International;2012, Vol. 12 Issue 1, p29 

    Background: While breast cancer (BC) is the major cause of death among women worldwide, there is no guarantee of better patient survival because many of these patients develop primarily metastases, despite efforts to detect it in its early stages. Bone metastasis is a common complication that...

  • An economic model of long-term use of celecoxib in patients with osteoarthritis. Loyd, Michael; Rublee, Dale; Jacobs, Philip // BMC Gastroenterology;2007, Vol. 7, p25 

    Background: Previous evaluations of the cost-effectiveness of the cyclooxygenase-2 selective inhibitor celecoxib (Celebrex, Pfizer Inc, USA) have produced conflicting results. The recent controversy over the cardiovascular (CV) risks of rofecoxib and other coxibs has renewed interest in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics